by Clare Gerrard | Mar 26, 2025
Neuroendocrine Cancer UK are delighted that our article. ‘Are NENs no longer a rare cancer?’ has been published in the March edition of Neuroendocrinology. For the patient community, this article is a powerful step forward. It highlights the need for better...
by Clare Gerrard | Feb 24, 2025
A recently published report from Public Policy Projects (PPP) and Civica recommends accelerating the uptake of digital technology integration to improve cancer pathway outcomes. The report, titled “Improving cancer pathways: Challenges, Overcoming Barriers and...
by Clare Gerrard | Feb 18, 2025
The National Institute for Health and Care Excellence (NICE) set up the NICE Prioritisation Board to help decide topics for guidance development see more information. NICE are looking for two people to join the board to bring a perspective of patients, people who use...
by Clare Gerrard | Feb 4, 2025
February is always an important month for Neuroendocrine Cancer UK. It is the month of World Cancer Day and Rare Disease Day which gives us the perfect opportunity to talk about the unmet needs of this misunderstood cancer. World Cancer Day is a poignant reminder of...
by Clare Gerrard | Nov 4, 2024
UK Government announces commitment to a National Cancer Strategy for England Several weeks ago, Neuroendocrine Cancer UK, and fellow charities, co-signed the joint One Cancer Voice letter to the Secretary of State for Health and Social Care, Wes Streeting,...
